Arcutis Biotherapeutics Inc (ARQT NASDAQ) stock market data APIs
$28.4051
0.01(0%)
as of December 17, 2025
Try our APIs with
free plan!
Arcutis Biotherapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE foam for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-255, a selective small molecule inhibitor of JAK1 for the treatment of alopecia areata; ARQ-252, a JAK1-selective topical cream in development for hand eczema and vitiligo; and ARQ-234, a CD200R fusion protein for the treatment of atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Prev. Close
28.4051
Open
28.416
High
28.4497
Low
28.0559
52 wk Range
11.13-31.77
Market Cap
3 471 M
Shares Outstanding
122 M
Revenue
318 M
EPS
0.06
Beta
1.703
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Arcutis Biotherapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Arcutis Biotherapeutics Inc data using free add-ons & libraries
Get Arcutis Biotherapeutics Inc Fundamental Data
Arcutis Biotherapeutics Inc Fundamental data includes:
- Net Revenue: 318 M
- EBITDA: -33 189 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: -0.1004
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Arcutis Biotherapeutics Inc News
New
5 Biotech Stocks to Watch for Potential Upside
The volatile biotech industry has put up a strong performance in 2025 despite the uncertain macroeconomic environment. While the tariff saga hit the pharma/biotech industry earlier in the year, the se...
Assessing Arcutis Biotherapeutics After 99% YTD Surge and Mixed Valuation Signals
If you are wondering whether Arcutis Biotherapeutics is still worth a closer look after its big run up, or if most of the upside is already priced in, this article is for you. The stock has been volat...
This Biotech Stock Could Cure Your Portfolio's Pain
Key Points Arcutis already has its key drug approved for various diseases and concentrations. Sales are expanding rapidly, and Arcutis is positioned for growth. 10 stocks we like better than Arcutis ...
This Biotech Stock Could Cure Your Portfolio's Pain
Key Points Arcutis already has its key drug approved for various diseases and concentrations. Sales are expanding rapidly, and Arcutis is positioned for growth. 10 stocks we like better than Arcutis ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
